Evidence map›Paper›PMID 35734547›Full record

ReviewJournal of multimorbidity and comorbidity

Multimorbidity matters in low and middle-income countries.

Ana Basto-Abreu, Tonatiuh Barrientos-Gutierrez, Alisha N Wade, Daniela Oliveira de Melo, Ana S Semeão de Souza, Bruno P Nunes, Arokiasamy Perianayagam, Maoyi Tian, Lijing L Yan, Arpita Ghosh and 1 more

Abstract readReview
In one paragraph

Review in Journal of multimorbidity and comorbidity. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Prevalence of Multimorbidity in the Middle East: A Systematic Review of Observational Studies.International journal of environmental research and public health · 2022
    Pooled it
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ana Basto-AbreuCenter for Population Health Research, National Institute of Public Health, Cuernavaca, Mexico.ORCID https://orcid.org/0000-0003-1600-4797
Tonatiuh Barrientos-GutierrezCenter for Population Health Research, National Institute of Public Health, Cuernavaca, Mexico.ORCID https://orcid.org/0000-0002-0826-9106
Alisha N WadeMRC/Wits Rural Public Health and Health Transitions Research Unit, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Daniela Oliveira de MeloDepartment of Pharmaceutical Sciences, Universidade Federal de São Paulo, São Paulo, Brazil.
Ana S Semeão de SouzaInstitute of Social Medicine, State University of Rio de Janeiro, Rio de Janeiro, Brazil.
Bruno P NunesDepartment of Nursing in Public Health, Universidade Federal de Pelotas, Pelotas, Brazil.
Arokiasamy PerianayagamInternational Institute for Population Sciences, Mumbai, India.
Maoyi TianThe George Institute for Global Health, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.
Lijing L YanGlobal Health Research Center, Duke Kunshan University, Kunshan, China.
Arpita GhoshThe George Institute for Global Health, New Delhi, India.
J Jaime MirandaCRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.ORCID https://orcid.org/0000-0002-4738-5468

Funding

Household Air Pollution and Health: A Multi-Country LPG Intervention TrialUM1HL134590 · NHLBI · EMORY UNIVERSITY · PI CHECKLEY, WILLIAM, CLASEN, THOMAS F · 2016 to 2021
$31.1M
Latin America Treatment & Innovation Network in Mental Health (LATIN-MH)U19MH098780 · NIMH · FUNDACAO FACULDADE DE MEDICINA · PI ARAYA, RICARDO, MENEZES, PAULO ROSSI · 2013 to 2017
$2.7M
Launching a salt substitute to reduce blood pressure at the population level-PeruU01HL114180 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI GILMAN, ROBERT H · 2012 to 2016
$2.0M
Endocrine and metabolic diseases in rural South Africa-establishing burden and improving detectionK43TW010698 · FIC · WITS HEALTH CONSORTIUM (PTY), LTD · PI WADE, ALISHA NICOLE · 2017 to 2021
$581k
Building sustainable and innovative research in Cancer and Cardiovascular disease: Planning the design and development of the South American Center of Research Excellence to Counter NCDs (SACREN)P20CA217231 · NCI · INSTITUTO DE EFECTIVIDAD CLINICA Y SANIT · PI IRAZOLA, VILMA · 2017 to 2018
$497k
Implementation of foot thermometry and SMS to prevent diabetic foot ulcerR21TW009982 · FIC · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI MIRANDA, J JAIME · 2014 to 2015
$329k
Using Burden of Treatment as a Clinical Indicator of Barriers to Multimorbidity Management in Peru: A Mixed Methods ApproachR21TW011740 · FIC · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI CUBA , MARIA SOFIA · 2020 to 2021
$297k
Planning to Establish a Regional Center of NCD Research Training in PeruD71TW010877 · FIC · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI MIRANDA, J JAIME · 2017 to 2017
$50k
FIC NIH HHS D71 TW010877FIC NIH HHS K43 TW010698FIC NIH HHS R21 TW009982FIC NIH HHS R21 TW011740NCI NIH HHS P20 CA217231NHLBI NIH HHS HHSN268200900033CNHLBI NIH HHS U01 HL114180NHLBI NIH HHS UM1 HL134590NIMH NIH HHS U19 MH098780Wellcome Trust 205177/Z/16/Z
6 · The paper itself

Abstract

Multimorbidity is a complex challenge affecting individuals, families, caregivers, and health systems worldwide. The burden of multimorbidity is remarkable in low- and middle-income countries (LMICs) given the many existing challenges in these settings. Investigating multimorbidity in LMICs poses many challenges including the different conditions studied, and the restriction of data sources to relatively few countries, limiting comparability and representativeness. This has led to a paucity of evidence on multimorbidity prevalence and trends, disease clusters, and health outcomes, particularly longitudinal outcomes. In this paper, based on our experience of investigating multimorbidity in LMICs contexts, we discuss how the structure of the health system does not favor addressing multimorbidity, and how this is amplified by social and economic disparities and, more recently, by the COVID-19 pandemic. We argue that generating epidemiologic data around multimorbidity with similar methods and definition is essential to improve comparability, guide clinical decision-making and inform policies, research priorities, and local responses. We call for action on policy to refinance and prioritize primary care and integrated care as the center of multimorbidity.

Indexed as

epidemiologyevidence-basedlow- and middle-income countriesmultimorbidity

Identifiers

PMID35734547
PMCPMC9208045

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.